Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2‐VASc Scores: Findings From the ORBIT‐AF I and II Registries

Background Current American College of Cardiology/American Heart Association guidelines suggest that for patients with atrial fibrillation who are at low risk for stroke (CHA2DS2VASc=1) (or women with CHA2DS2VASc=2) a variety of treatment strategies may be considered. However, in clinical practice,...

Full description

Bibliographic Details
Main Authors: Larry R. Jackson, Sunghee Kim, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, Peter R. Kowey, Kenneth W. Mahaffey, Daniel Singer, Laine Thomas, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini
Format: Article
Language:English
Published: Wiley 2018-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
oral anticoagulation
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF)
stroke
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.008764

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.008764

Similar Items